Drug-eluting stents with CD34 antibodies for the treatment of coronary artery disease
Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)
Record ID 32015000815
English
Authors' recommendations:
Despite a lack of comparative evidence on the safety and effectiveness of CD34 stents, this technology is likely to diffuse rapidly into the public health system and may represent a considerable financial burden to the jurisdictions. HealthPACT therefore recommend that this technology should only be used in the context of research until such data supporting its clinical effectiveness is made available from appropriate comparative studies.
Details
Project Status:
Completed
Year Published:
2014
URL for published report:
http://www.health.qld.gov.au/healthpact/docs/briefs/WP180.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Australia
MeSH Terms
- Coronary Artery Disease
- Coronary Artery Bypass
- Percutaneous Coronary Intervention
- Antigens, CD34
Contact
Organisation Name:
Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
Contact Address:
ASERNIP-S 24 King William Street, Kent Town SA 5067 Australia Tel: +61 8 8219 0900
Contact Name:
racs.asernip@surgeons.org
Contact Email:
racs.asernip@surgeons.org
Copyright:
State of Queensland (Queensland Department of Health) 2014
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.